Regulation of B Lymphocyte Development and Activation bythe CD19/CD21/CD81/Leu 13 Complex Requires the Cytoplasmic Domain of CD19

Journal of Immunology

Volumn 159, Issue 7, 1997, Pages 3278-3287

  Sato, Shinichi ^a   Miller, Ann S ^a   Howard, Maureen C ^b   Tedder, Thomas F ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CD19 ANTIGEN; CD81 ANTIGEN; COMPLEMENT COMPONENT C3D RECEPTOR; DIFFERENTIATION ANTIGEN; IMMUNOGLOBULIN; IMMUNOGLOBULIN M; LEU 13 ANTIGEN; LEU-13 ANTIGEN; LEUKOCYTE ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR; MEMBRANE PROTEIN;

ANIMAL; ARTICLE; B LYMPHOCYTE; BIOSYNTHESIS; C57BL MOUSE; CELL DIFFERENTIATION; CHEMISTRY; CYTOLOGY; CYTOPLASM; DRUG EFFECT; FEMALE; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MALE; METABOLISM; MOUSE; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD19; ANTIGENS, DIFFERENTIATION; B-LYMPHOCYTE SUBSETS; CALCIUM; CELL DIFFERENTIATION; CYTOPLASM; FEMALE; IMMUNOGLOBULIN M; IMMUNOGLOBULINS; LYMPHOCYTE ACTIVATION; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, ANTIGEN, B-CELL; RECEPTORS, COMPLEMENT 3D;

EID: 0031253851     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Tedder, T. F., M. Inaoki, and S. Sato. 1997. The CD19/21 complex regulates signal transduction thresholds governing humoral immunity and autoimmunity. Immunity 6:107.
2. Bradbury, L., G. S. Kansas, S. Levy, R. L. Evans, and T. F. Tedder. 1992. CD19 is a component of a signal transducing complex on the surface of B cells that includes CD21, TAPA-1 and Leu-13. J. Immunol. 149:2841.
3. Matsumoto, A. K., J. Kopicky-Burd, R. H. Carter, D. A. Tuveson, T. F. Tedder, and D. T. Fearon. 1991. Intersection of the complement and immune systems: a signal transduction complex of the B lymphocyte containing complement receptor type 2 and CD19. J. Exp. Med. 173:55.
4. Krop, I., A. L. Shaffer, D. T. Fearon, and M. S. Schlissel. 1996. The signaling activity of murine CD19 is regulated during B cell development. J. Immunol. 157:48.
5. Tedder, T. F., L.-J. Zhou, and P. Engel. 1994. The CD19/CD21 signal transduction complex of B lymphocytes. Immunol. Today 15:437.
6. Fearon, D. T., and R. H. Carter. 1995. The CD19/CR2/TAPA-1 complex of B lymphocytes: linking natural to acquired immunity. Annu. Rev. Immunol. 13:127.
7. Engel, P., L.-J. Zhou, D. C. Ord, S. Sato, B. Koller, and T. F. Tedder. 1995. Abnormal B lymphocyte development, activation and differentiation in mice that lack or overexpress the CD19 signal transduction molecule. Immunity 3:39.
8. Rickert, R. C., K. Rajewsky, and J. Roes. 1995. Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice. Nature 376: 352.
9. Sato, S., D. A. Steeber, and T. F. Tedder. 1995. The CD19 signal transduction molecule is a response regulator of B-lymphocyte differentiation. Proc. Natl. Acad. Sci. USA 92:11558.
10. Sato, S., D. A. Steeber, P. J. Jansen, and T. F. Tedder. 1997. CD19 expression levels regulate B lymphocyte development: human CD19 restores normal function in mice lacking endogenous CD19. J. Immunol. 158:4662.
11. Sato, S., N. Ono, D. A. Steeber, D. S. Pisetsky, and T. F. Tedder. 1996. CD19 regulates B lymphocyte signaling thresholds critical for the development of B-1 lineage cells and autoimmunity. J. Immunol. 156:4371.
12. Zhou, L.-J., H. M. Smith, T. J. Waldschmidt, R. Schwarting, J. Daley, and T. F. Tedder. 1994. Tissue-specific expression of the human CD19 gene in transgenic mice inhibits antigen-independent B lymphocyte development. Mol. Cell. Biol. 14:3884.
13. Ahearn, J. M., M. B. Fischer, D. Croix, S. Goerg, M. Ma, J. Xia, X. Zhou, R. G. Howard, T. L. Rothstein, and M. C. Carroll. 1996. Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen. Immunity 4:251.
14. Molina, H., V. M. Holers, B. Li, Y.-F. Fang, S. Mariathasan, J. Goellner, J. Strauss-Schoenberger, R. W. Karr, and D. D. Chaplin. 1996. Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2. Proc. Natl. Acad. Sci. USA 93:3357.
15. Tedder, T. F., and C. M. Isaacs. 1989. Isolation of cDNAs encoding the CD19 antigen of human and mouse B lymphocytes: a new member of the immunoglobulin superfamily. J. Immunol. 143:712.
16. Zhou, L.-J., D. C. Ord, A. L. Hughes, and T. F. Tedder. 1991. Structure and domain organization of the CD19 antigen of human, mouse and guinea pig B lymphocytes: conservation of the extensive cytoplasmic domain. J. Immunol. 147:1424.
17. Bradbury, L. E., V. S. Goldmacher, and T. F. Tedder. 1993. The CD19 signal transduction complex of B lymphocytes: deletion of the CD19 cytoplasmic domain alters signal transduction but not complex formation with TAPA-1 and Leu-13. J. Immunol. 151:2915.
18. Matsumoto, A. K., D. R. Martin, R. H. Carter, L. B. Klickstein, J. M. Ahearn, and D. T. Fearon. 1993. Functional dissection of the CD21/CD19/TAPA-1/Leu-13 complex of B lymphocytes. J. Exp. Med. 178:1407.
19. van Noesel, C. J. M., A. C. Lankester, and R. A. W. van Lier. 1993. Dual antigen recognition by B cells. Immunol. Today 14:8.
20. Uckun, F. M., A. L. Burkhardt, L. Jarvis, X. Jun, B. Stealey, I. Dibirdik, D. E. Myers, L. Tuel-Ahlgren, and J. B. Bolen. 1993. Signal transduction through the CD19 receptor during discrete developmental stages of human B-cell ontogeny. J. Biol. Chem. 268:21772.
21. Weng, W. K., L. Jarvis, and T. W. LeBien. 1994. Signaling through CD19 activates vav/mitogen-activated protein kinase pathway and induces formation of a CD19/vav/phosphalidylinositol 3-kinase complex in human B cell precursors. J. Biol. Chem. 269:32514.
22. Chalupny, N. J., A. Aruffo, J. M. Esselstyn, P. Y. Chan, J. Bajorath, J. Blake, L. K. Gilliland, J. A. Ledbetter, and M. A. Tepper. 1995. Specific binding of Fyn and phosphatidylinositol 3-kinase to the B cell surface glycoprotein CD19 through their src homology 2 domains. Eur. J. Immunol. 25:2978.
23. Tuveson, D. A., R. H. Carter, S. P. Soltoff, and D. T. Fearon. 1993. CD19 of B cells as a surrogate kinase insert region to bind phosphatidylinositol 3-kinase. Science 260:986.
24. Kurtz, C. B., E. O'Toole, S. M. Christensen, and J. H. Weis. 1990. The murine complement receptor gene family. IV. Alternative splicing of Cr2 gene transcripts predicts two distinct gene products that share homologous domains with both human CR2 and CR1. J. Immunol. 144:3581.
25. Molina, H., T. Kinoshita, K. Inoue, J.-C. Carel, and V. M. Holers. 1990. A molecular and immunochemical characterization of mouse CR2: evidence for a single gene model of mouse complement receptors 1 and 2. J. Immunol. 145: 2974.
26. Levy, S., V. Q. Nguyen, M. L. Andria, and S. Takahashi. 1991. Structure and membrane topology of TAPA-1. J. Biol. Chem. 266:14597.
27. Schick, M. R., V. Q. Nguyen, and S. Levy. 1993. Anti-TAPA-1 antibodies induce protein tyrosine phosphorylation that is prevented by increasing intracellular thiol levels. J. Immunol. 151:1918.
28. Maecker, H. T., S. C. Todd, and S. Levy. 1997. The tetraspanin superfamily: molecular facilitators. FASEB J. 11:428.
29. Maecker, H. T., and S. Levy. 1997. Normal lymphocyte development but delayed humoral immune response in CD81-null mice. J. Exp. Med. 185:1505.
30. Lewin, A. R., L. E. Reid, M. McMahon, G. R. Stark, and I. M. Kerr. 1991. Molecular analysis of a human interferon-inducible gene family. Eur. J. Biochem. 199:417.
31. Deblandre, G. A., O. P. Marinx, S. S. Evans, S. Majjaj, O. Leo, D. Caput, G. A. Huez, and M. G. Wathelet. 1995. Expression cloning of an interferon-inducible 17-kDa membrane protein implicated in the control of cell growth. J. Biol. Chem. 270:23860.
32. Kansas, G. S., and T. F. Tedder. 1991. Transmembrane signals generated through MHC class II, CD19, CD20, CD39, and CD40 antigens induce LFA-1-dependent and independent adhesion in human B cells through a tyrosine kinase-dependent pathway. J. Immunol. 147:4094.
33. Santos-Argumedo, L., C. Teixeira, G. Preece, P. A. Kirkham, and R. M. Parkhouse. 1993. A B lymphocyte surface molecule mediating activation and protection from apoptosis via calcium channels. J. Immunol. 151:3119.
34. Heath, A. W., W. W. Wu, and M. C. Howard. 1994. Monoclonal antibodies to murine CD40 define two distinct functional epitopes. Eur. J. Immunol. 24:1828.
35. Carter, R. H., M. O. Spycher, Y. C. Ng, R. Hoffman, and D. T. Fearon. 1988. Synergistic interaction between complement receptor type 2 and membrane IgM on B lymphocytes. J. Immunol. 141:457.
36. Tsokos, G. C., J. D. Lambris, F. D. Finkelman, E. D. Anastassiou, and C. H. June. 1990. Monovalent ligands of complement receptor 2 inhibit whereas polyvalent ligands enhance anti-Ig-induced human B cell intracytoplasmic free calcium concentration. J. Immunol. 144:1640.
37. Pramoonjago, P., J. Takeda, Y. U. Kim, K. Inoue, and T. Kinoshita. 1993. Ligand specificities of mouse complement receptors types 1 (CR1) and 2 (CR2) purified from spleen cells. Int. Immunol. 5:337.
38. Molina, H., T. Kinoshita, C. B. Webster, and V. M. Holers. 1994. Analysis of C3b/C3d binding sites and factor I cofactor regions within mouse complement receptors 1 and 2. J. Immunol. 153:789.
39. Andria, M., L., C.-L. Hsieh, R. Oren, U. Francke, and S. Levy. 1991. Genomic organization and chromosomal localization of the TAPA-1 gene. J. Immunol. 147:1030.
40. Moore, M. D., N. R. Cooper, B. F. Tack, and G. R. Nemerow. 1987. Molecular cloning of the cDNA encoding the Epstein-Barr virus/C3d receptor (complement receptor type 2) of human B lymphocytes. Proc. Natl. Acad. Sci. USA 84:9194.